. Author manuscript; available in PMC: 2019 Jul 29.

Published in final edited form as: Urol Oncol. 2015 Mar 6;33(5):202.e1–202.e7. doi: 10.1016/j.urolonc.2015.01.023

Table 1.

Patient demographics for the initial and follow-up cohorts.

Patient Characteristic	Initial	Follow-Up

Number of men	152	58
Age, mean ± SD (range)	61.4 ± 7.1 years (40-79)	61.3 ± 7.02 years (45-77)
PSA, ng/mL, mean ± SD (range)	5.2 ± 3.2 ng/mL (0.2-23.3)	5.0 ± 3.1 ng/mL (0.2-20.0)
PSA density, mean ± SD (range)	0.09 ± 0.03 ng/mL² (0.01-0.15)	0.09 ± 0.04 ng/mL² (0.01-0.15)
Clinical stage
T1c	152	58
Race (%)
White	127 (83.6%)	51 (88%)
African-American	21 (13.8%)	7 (12%)
Other	4 (2.6%)	0

Prostate volume, mean ± SD (range)	58 ± 28 cm³ (23-161)	56 ± 25 cm³ (22-146)
Number of lesions, mean ± SD (range)	2.3 ± 1.2 (1-9)	2.3 ± 1.1 (1-5)
Highest suspicion score, (%)
Low	32 (21.1%)	18 (31%)
Moderate	109 (71.7%)	36 (62%)
High	11 (7.2%)	4 (7%)

Abbreviations: PSA, prostate-specific antigen; SD, standard deviation.